Skip to main content
. 2022 Apr;63(4):528–535. doi: 10.2967/jnumed.121.262542

FIGURE 6.

FIGURE 6.

Patient 26. (A) Immunohistochemistry analysis shows very low HER2 expression in biopsy material. (B) Anterior planar image at 4 h after injection; upper setting of scale window is 12% of maximum counts, showing tumor–to–contralateral site ratio typical for HER2-positive tumors. Immunohistochemistry analysis of surgery material shows areas with high (B) and low (C) HER2 expression. Magnification 400×. Black arrows show cells with low and red arrows show cells with high HER2 expression. Arrows point at tumor.